Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2008, Vol. 2 Issue (2) : 200-203    https://doi.org/10.1007/s11684-008-0038-6
Expression of heat shock protein gp96 in osteosarcoma and its clinical significance
GUO Weichun1, CHEN Anmin2
1.Department of Orthopaedics, Tongji Medical College, Huazhong University of Science & Technology;Department of Orthopaedics, Renmin Hospital of Wuhan University; 2.Department of Orthopaedics, Tongji Medical College, Huazhong University of Science & Technology;
 Download: PDF(184 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract This study aims to detect the expression of heat shock protein gp96 (HSPgp96) in osteosarcoma and explore its role in anti-tumor immunity. Expression of HSPgp96 in 45 cases of osteosarcoma, including 24 cases of the osteoblast type, 21 cases of chondroblast type and 5 cases of normal bone tissue were detected by immunohistochemistry (IHC). The expression rate of HSPgp96 was 100% (45/45) in osteosarcoma, compared with 20% (1/5) in normal bone tissue. The average positive cell rates were 97.23% and 0.48% in osteosarcoma and normal bone tissue, respectively, and the difference between them was significant (P < 0.01). The positive cell rates in osteoblast type and chondroblast type were 97.78% and 96.56%, respectively, and the difference had no statistical significance (P > 0.05). The expression degree of HSPgp96 in osteosarcoma had a clear correlation with the pathologic degree (P < 0.05), while it had no relationship with the clinical stage (P > 0.05). The expression of HSPgp96 is high in osteosarcoma and it may be a significant index for judgment of malignancy degree and an important target site of anti-tumor immunity.
Issue Date: 05 June 2008
 Cite this article:   
CHEN Anmin,GUO Weichun. Expression of heat shock protein gp96 in osteosarcoma and its clinical significance[J]. Front. Med., 2008, 2(2): 200-203.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-008-0038-6
https://academic.hep.com.cn/fmd/EN/Y2008/V2/I2/200
1 Théoleyre S Mori K Cherrier B Passuti N Gouin F Rédini F Heymann D Phenotypic and functional analysisof lymphocytes infiltrating osteolytic tumors: use as a possible therapeuticapproach of osteosarcomaBMC Cancer 2005 5123.
doi: 10.1186/1471‐2407‐5‐123
2 Link M P Goorin A M Horowitz M Meyer W H Belasco J Baker A Ayala A Shuster J Adjuvant chemotherapy of high-grade osteosarcoma of theextremity. Updated results of the multi-institutional osteosarcomastudyClin Orthop Relat Res 1991 (270)814
3 Provisor A J Ettinger L J Nachman J B Krailo M D Makley J T Yunis E J Huvos A G Betcher D L Baum E S Kisker C T Miser J S Treatmentof non-metastatic osteosarcoma of the extremity with pre-operativechemotherapy: a report from the Children's Cancer GroupJ Clin Oncol 1997 15(1)7684
4 Binder R J Kelly J B Vatner R F Srivastava P K SpecificImmunogenicity of Heat Shock Protein gp96 Derives from ChaperonedAntigenic Peptides and Not from Contaminating ProteinsJ Immunol 2007 1179(11)72547261
5 Podack E R Raez L E Allogeneic tumor-cell-basedvaccines secreting endoplasmic reticulum chaperone gp96Expert Opin Biol Ther 2007 7(11)16791688.
doi:10.1517/14712598.7.11.1679
6 Amato R J Heat-shockprotein-peptide complex-96 for the treatment of cancerExpert Opin Biol Ther 2007 7(8)12671273.
doi:10.1517/14712598.7.8.1267
7 Srivastava P K Menoret A Basu S Binder R J McQuade K L Heat shock proteins come of age: primitivefunctions acquire new roles in an adaptive worldImmunity 1998 8(6)657665.
doi:10.1016/S1074‐7613(00)80570‐1
8 Altmeyer A Maki R G Feldweg A M Heike M Protopov V P Masur S K Srivastava P K Tumor-specific cell surfaceexpression of KDEL-containing, endoplasmic reticular heat shock proteingp96Int J Cancer 1996 69(4)340349.
doi:10.1002/(SICI)1097‐0215(19960822)69:4<340::AID‐IJC18>3.0.CO;2‐9
9 Robert J Menoret A Cohen N Cell surface expression of the endoplasm micreticular heatshock protein gp96 is phylogenetically conservedJ Immunol 1999 163(8)41334139
10 Kimura E Enns R E Alcaraz J E Alboleda J Slamon D J Howell S B Correlationof the survival of ovarian cancer patients with mRN A expression ofthe 60-kD heat-shock protein HSP-60J ClinOncol 1993 11(5)891898
11 Ullrich S J Robinson E A Law L W Willingham M Appella E A mouse tumor-specific transplantationantigen is a heat shock-related proteinProc Natl Acad Sci USA 1986 83(10)31213125.
doi:10.1073/pnas.83.10.3121
12 Xu X F Shi Y J Tang P Z Heat shock protein and tumorGuo Wai Yi Xue Er Bi Yan Hou Ke Fen Ce 1998 2225(in Chinese)
13 Young R A Stressproteins and immunologyAnnu Rev Immunol 1990 8401.
doi: 10.1146/annurev.iy.08.040190.002153
14 Melcher A Todryk S Hardwick N Ford M Jacobson M Vile R G Tumorimmunogenicity is determined by mechanism of cell death via inductionof heat shock protein expressionNat Med 1998 4(5)581587.
doi:10.1038/nm0598‐581
15 Suto R Srivastava P K A mechanism for the specificimmunogenicity of heat shock protein-chaperoned peptidesScience 1995 269(5230)15851588.
doi:10.1126/science.7545313
16 Qu J L Xu H M Yan Y Expression and Detection of Chaperone Proteins in HumanGastric CancerShi Jie Hua Ren Xiao HuaZa Zhi 2005 13(15)18091813(in Chinese)
17 Trieb K Lang S Kotz R Heat-shock protein 72 in human osteosarcoma: T-lymphocytesreactivity and cytotoxicityPediatr HematolOncol 2000 17(5)355364.
doi:10.1080/08880010050034283
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed